(Rac) -Nutlin-3

(Rac) -Nutlin-3 (Rebemadlin), an active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC50=90 nM) . (Rac) -Nutlin-3 inhibits MDM2-p53 interactions and stabilizes the p53 protein, and induces cell autophagy and apoptosis. (Rac) -Nutlin-3 has the potential for the study of TP53 wild-type ovarian carcinomas[1][2].

Product Specifications

CAS Number

[890090-75-2]

Product Name Alternative

(Rac) -Rebemadlin

UNSPSC

12352005

Hazard Statement

H302

Target

Apoptosis; Autophagy; E1/E2/E3 Enzyme; MDM-2/p53

Type

Reference compound

Related Pathways

Apoptosis; Autophagy; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/rac-nutlin-3.html

Purity

98.18

Solubility

10 mM in DMSO

Smiles

O=C(N1C(C2=C(C=C(C=C2)OC)OC(C)C)=NC(C3=CC=C(C=C3)Cl)C1C4=CC=C(C=C4)Cl)N5CC(NCC5)=O

Molecular Formula

C30H30Cl2N4O4

Molecular Weight

581.49

Precautions

P264-P270-P330-P501

References & Citations

[1]Crane EK, et al. Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS One. 2015 Aug 6;10 (8) :e0135101.|[2]Tovar C, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A. 2006 Feb 7;103 (6) :1888-93.|[3]M Ulrich, et al. Murine tumor models for the in vivo evaluation of natural compounds and their derivatives as new cancer therapeutics. München. 2016.